Melanoma / Skin Cancer Clinical Trials
For more information about a clinical trial,
clinical trial eligibility, or informed consent,
contact our research nurses by phone or email:
Please Note: The eligibility criteria noted below are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any treatment to be undertaken must ultimately be determined on an individual basis by the patient and those involved in the patient's treatment. |
Melanoma Clinical Trials
| Study Title | ||||
|---|---|---|---|---|
| Body Location | Study # | Primary Investigator | More Info | |
Immunologic Evaluation of Peripheral Blood | ||||
| Brain and Nervous System, Kidney, Melanoma, skin, Other Urinary, Urinary Bladder | D0229 | Ernstoff | More Info | |
Open-label pharmacokinetic trial of aldesleukin (rhinterleukin-2 [IL-2]) administered intravenously to subjects with metastatic renal cell carcinoma or metastatic melanoma with immunologic correlative studies | ||||
| Kidney, Melanoma, skin | F0819 | Ernstoff | More Info | |
PCR Assay to Detect Minimal Residual Melanoma in Peripheral Blood of Patients Treated with Adjuvant Interferon Alpha-2b | ||||
| Melanoma, skin | D9802 | Perez | More Info | |
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Evaluating The Efficacy Of ABT-888 In Combination With Temozolomide Versus Temozolomide Alone In Subjects With Metastatic Melanoma | ||||
| Melanoma, skin | F0855 | Ernstoff | More Info | |
A Phase II Study of Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma and Melanomas That Arise on Chronically Sun Damaged Skin | ||||
| Melanoma, skin | W0824 | Ernstoff | More Info | |
